AngioLab, Inc.
Develops angiogenesis inhibitors for pharmaceuticals and health functional foods.
251280 | KO
Overview
Corporate Details
- ISIN(s):
- KR7251280004
- LEI:
- Country:
- South Korea
- Address:
- 대전광역시 유성구 테크노3로 65, 대전광역시
- Website:
- https://angiolab.co.kr/
Description
AngioLab, Inc. is a biotechnology company specializing in the discovery and development of angiogenesis inhibitors. The company develops pharmaceuticals and health functional foods to treat diseases associated with the abnormal growth of blood vessels. Its pipeline includes drug candidates targeting conditions such as age-related macular degeneration (AMD), with some candidates having undergone Phase II clinical trials. AngioLab has also developed Ob-X, a functional food ingredient based on its anti-angiogenic research platform.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2021-12-14 00:00 |
주주명부폐쇄기간또는기준일설정
|
Korean | 4.1 KB | ||
| 2021-12-09 00:00 |
특허권취득(자율공시)
|
Korean | 5.8 KB | ||
| 2021-12-09 00:00 |
주식등의대량보유상황보고서(약식)
|
Korean | 56.9 KB | ||
| 2021-12-08 00:00 |
주식등의대량보유상황보고서(약식)
|
Korean | 66.1 KB | ||
| 2021-12-06 00:00 |
주식등의대량보유상황보고서(약식)
|
Korean | 61.7 KB | ||
| 2021-11-30 00:00 |
증권발행결과(자율공시)(제3자배정 유상증자)
|
Korean | 5.1 KB | ||
| 2021-11-17 00:00 |
주요사항보고서(유상증자결정)
|
Korean | 39.2 KB | ||
| 2021-11-11 00:00 |
기업설명회(IR)개최결과
|
Korean | 6.6 KB | ||
| 2021-10-27 00:00 |
기업설명회(IR)개최
|
Korean | 6.9 KB | ||
| 2021-09-16 00:00 |
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 24.3 KB | ||
| 2021-08-30 00:00 |
주식등의대량보유상황보고서(약식)
|
Korean | 80.2 KB | ||
| 2021-08-13 00:00 |
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 25.1 KB | ||
| 2021-08-11 00:00 |
주식등의대량보유상황보고서(약식)
|
Korean | 80.5 KB | ||
| 2021-08-04 00:00 |
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 23.6 KB | ||
| 2021-07-28 00:00 |
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 25.1 KB |
Automate Your Workflow. Get a real-time feed of all AngioLab, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for AngioLab, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for AngioLab, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
